Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GERARD A SILVESTRI

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1417922865
CMS profile
199983
Location
CHARLESTON, SC

General Payments · PY2018–2024

$256,105.17

  • Reported across 197 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$31,163.73

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $27,786.60 10
PY2019 $60,160.28 41
PY2020 $74,563.60 64
PY2021 $20,159.18 3
PY2022 $20,787.78 27
PY2023 $21,484.00 19
PY2024 $31,163.73 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $805.50 04/01/2024 Consulting Fee Undisputed 01/23/2026 1105672459 CMS
AstraZeneca Pharmaceuticals LP $83.04 09/08/2024 Food and Beverage Undisputed 01/23/2026 1105587496 CMS
AstraZeneca Pharmaceuticals LP $62.29 09/09/2024 Food and Beverage Undisputed 01/23/2026 1105800895 CMS
AstraZeneca Pharmaceuticals LP $805.50 10/22/2024 Consulting Fee Undisputed 01/23/2026 1104783836 CMS
AstraZeneca Pharmaceuticals LP $4,027.50 12/19/2024 Consulting Fee Undisputed 01/23/2026 1104637417 CMS
Boehringer Ingelheim International GmbH $2,425.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1118001933 CMS
Exact Sciences Corporation $880.00 05/02/2024 Consulting Fee Undisputed 01/23/2026 1125640452 CMS
Medtronic, Inc. $100.29 05/20/2024 Food and Beverage Undisputed 01/23/2026 1119310662 CMS
Medtronic, Inc. $485.00 05/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1112052193 CMS
Olympus America Inc. $1,320.00 01/17/2024 Education Undisputed 01/23/2026 1108466942 CMS
Olympus America Inc. $440.00 03/07/2024 Consulting Fee Undisputed 01/23/2026 1108466940 CMS
Olympus Corporation of the Americas $660.00 03/27/2024 Consulting Fee Undisputed 01/23/2026 1110433737 CMS
Olympus Corporation of the Americas $330.00 04/01/2024 Consulting Fee Undisputed 01/23/2026 1110433739 CMS
Olympus Corporation of the Americas $1,320.00 04/01/2024 Consulting Fee Undisputed 01/23/2026 1110433741 CMS
Olympus Corporation of the Americas $2,200.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 1110433719 CMS
Olympus Corporation of the Americas $440.00 05/22/2024 Education Undisputed 01/23/2026 1110433743 CMS
Olympus Corporation of the Americas $184.80 07/11/2024 Consulting Fee Undisputed 01/23/2026 1110433735 CMS
Olympus Corporation of the Americas $655.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1110433721 CMS
Olympus Corporation of the Americas $1,310.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1110433723 CMS
Olympus Corporation of the Americas $982.50 08/08/2024 Consulting Fee Undisputed 01/23/2026 1110433725 CMS
Olympus Corporation of the Americas $655.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1110433727 CMS
Olympus Corporation of the Americas $655.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1110433729 CMS
Olympus Corporation of the Americas $655.00 08/08/2024 Consulting Fee Undisputed 01/23/2026 1110433731 CMS
Olympus Corporation of the Americas $1,637.50 08/08/2024 Consulting Fee Undisputed 01/23/2026 1110433733 CMS
Olympus Corporation of the Americas $655.00 11/21/2024 Consulting Fee Undisputed 01/23/2026 1110433745 CMS
Olympus Corporation of the Americas $1,965.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 1110433747 CMS
Olympus Corporation of the Americas $1,310.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 1110433749 CMS
Olympus Corporation of the Americas $655.00 11/25/2024 Consulting Fee Undisputed 01/23/2026 1110433751 CMS
Olympus Medical Systems Corporation $59.44 04/16/2024 Food and Beverage Undisputed 01/23/2026 1099611844 CMS
Olympus Medical Systems Corporation $73.50 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1099611846 CMS
Olympus Medical Systems Corporation $136.87 04/16/2024 Travel and Lodging Undisputed 01/23/2026 1099611848 CMS
Olympus Medical Systems Corporation $1,430.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 1099611850 CMS
Olympus Medical Systems Corporation $1,760.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 1099611852 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.